| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rojkjaer Lisa | EVP, Chief Medical Officer | RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO | /s/ Raymond Furey (Attorney-in-Fact) | 12 Feb 2026 | 0001846460 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RIGL | Common Stock | Tax liability | $130,102 | -3,758 | -19% | $34.62 | 15,959 | 10 Feb 2026 | Direct |